PRAMIPEXOLE ZENTIVA 0.18 mg, scored tablet 30 tablets
Active ingredients: Pramipexole dihydrochloride hydrate, Pramipexole
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PRAMIPEXOLE ZENTIVA 0,18 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) polyamide aluminium PVC-Aluminium de 30 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Dec 2010
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67696401CIP73968245CIP133400939682457Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PRAMIPEXOLE (DICHLORHYDRATE DE) MONOHYDRATÉcomprimé | — | SA |
| PRAMIPEXOLE BASEcomprimé | 0,18 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.